CO-DEVELOPMENT AND CO-COMMERCIALISATION AGREEMENTCo-Commercialisation Agreement • March 13th, 2017 • Adaptimmune Therapeutics PLC • Biological products, (no disgnostic substances) • England and Wales
Contract Type FiledMarch 13th, 2017 Company Industry JurisdictionTHIS CO-DEVELOPMENT AND CO-COMMERCIALISATION AGREEMENT (“Agreement”) is made and entered into on December 16, 2016 (“Effective Date”) BETWEEN